N/A - Trump IRA (Government Retirement Program)

Joe Liemandt is not recommending it as an investment but as a transformative education model. He describes it as 'the single best market if you're an entrepreneur to enter' — a multi-trillion dollar market with no competitors.

The host recommends the Trump IRA for gig workers, freelancers, and anyone without 401(k) access who earns under $35,500 single or $71,000 married, due to the $1,000 government match representing a guaranteed 50% return.

The host personally believes the Roth IRA is the superior choice for most people, especially young or low-tax-bracket earners, because contributions are made with after-tax dollars and all growth is tax-free. He provides an example of $7,500/year from age 20 to 65 yielding nearly $2.5 million tax-free.

The host acknowledges 401(k) plans are valuable for those with employer access, especially with employer matches, but criticizes the high fees and poor fund options in many employer-sponsored plans.

The host has a mixed view: he supports individual freedom to invest in alternative assets but warns that for the average person, private equity and private credit in 401(k) plans carry significantly higher fees, complexity, and risk. He believes most people are better off with simple index funds.

Chad built and sold this company to Unilever for $1B+ in 32 months. He continues to work on it and has 12 innovations in the pipeline. He believes they're '5 miles into a marathon' with massive growth ahead.

Chad cites Doctor Squatch as his primary brand inspiration. It sold to Unilever for $1.5B. He admires their approach of making personal care a joy for consumers through branding and partnerships.

Chad describes this as a potential $10 billion business idea — a platform that sits as a distribution layer for ACH transfers, automatically routing deposits to bills, savings, investments before the consumer needs willpower. He believes the infrastructure exists and someone will be acquired for $500M-$1B within 2 years.

Dr. Sinclair is chairman of the board of Life Biosciences, a company he mentions is ready to move forward with AI-discovered molecules for age reversal. He discusses the company's readiness for FDA trials and the need for hundreds of millions in funding. No stock ticker is provided as it appears to be a private company.

Shaan Puri mentions Ultra as a trending company in the non-nicotine pouch space that raised $11M and sold 1M cans in 6 months. He notes Austin Reif is very bullish on it.